0001193125-26-354036.txt : 20260817 0001193125-26-354036.hdr.sgml : 20260817 20260817160603 ACCESSION NUMBER: 0001193125-26-354036 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260817 DATE AS OF CHANGE: 20260817 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Invivyd, Inc. CENTRAL INDEX KEY: 0001832038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 851403134 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40703 FILM NUMBER: 261286699 BUSINESS ADDRESS: STREET 1: 205 CHURCH STREET CITY: NEW HAVEN STATE: CT BUSINESS PHONE: (781) 819-0080 MAIL ADDRESS: STREET 1: 205 CHURCH STREET CITY: NEW HAVEN STATE: CT FORMER COMPANY: FORMER CONFORMED NAME: Adagio Therapeutics, Inc. DATE OF NAME CHANGE: 20201112 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Lee Timothy Edward CENTRAL INDEX KEY: 0002025331 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O INVIVYD, INC. STREET 2: 205 CHURCH STREET CITY: NEW HAVEN STATE: CT 144 1 primary_doc.xml 144 0002025331 XXXXXXXX LIVE 0001832038 Invivyd, Inc. 001-40703 205 Church Street New Haven CT 06510 781-819-0080 Lee Timothy Edward Officer Common Stock Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza 8th Floor New York NY 10004
40800 29412.72 294758746 08/17/2026 Nasdaq
Common Stock 08/15/2026 Common Stock acquired upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan Issuer N 102000 08/15/2026 Equity Compensation Y This Form 144 reports shares to be sold to satisfy the Reporting Person's tax obligations upon vesting of a restricted stock unit award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan applicable to the Reporting Person. Aggregate Market Value of the sale is based on a closing price of $0.7209 for the Issuer's common stock on August 14, 2026. The actual number of shares sold will depend on the sale price of the Issuer's common stock at the time of sale. 08/17/2026 02/20/2025 /s/ Jill Andersen attorney-in-fact for Timothy Edward Lee